No abstract available
Keywords:
Aclasta; Actonel; Atelvia; Binosto; Boniva; Evenity; Evista; Forteo; Fosamax; Fosavance; Prolia; Reclast; Tymlos; abaloparatide; adverse effects; alendronate; bisphosphonates; denosumab; dosage; efficacy; ibandronate; osteoporosis; postmenopausal osteoporosis; pregnancy; raloxifene; risedronate; romosozumab; safety; teriparatide; zoledronic acid.
MeSH terms
-
Adaptor Proteins, Signal Transducing
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / pharmacology
-
Bone Density / drug effects
-
Bone Density Conservation Agents / administration & dosage
-
Bone Density Conservation Agents / adverse effects
-
Bone Density Conservation Agents / pharmacology
-
Bone Morphogenetic Proteins / antagonists & inhibitors*
-
Female
-
Genetic Markers
-
Humans
-
Osteoporosis, Postmenopausal / drug therapy*
-
Osteoporosis, Postmenopausal / physiopathology
-
Osteoporotic Fractures / prevention & control
Substances
-
Adaptor Proteins, Signal Transducing
-
Antibodies, Monoclonal
-
Bone Density Conservation Agents
-
Bone Morphogenetic Proteins
-
Genetic Markers
-
SOST protein, human
-
romosozumab